Corvus Pharmaceuticals, Inc. (CRVS)
14.01
-0.06
(-0.43%)
USD |
NASDAQ |
Mar 27, 16:00
14.01
0.00 (0.00%)
After-Hours: 20:00
Corvus Pharmaceuticals Total Assets (Quarterly) : 71.12M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 40.56B |
| Plus Therapeutics, Inc. | 16.32M |
| Geron Corp. | 571.08M |
| Nektar Therapeutics | 280.41M |
| Jaguar Health, Inc. | 49.47M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 9.914M |
| Shareholders Equity (Quarterly) | 61.20M |
| Debt to Equity Ratio | 0.0153 |
| Current Ratio | 6.206 |
| Net Debt Paydown Yield | -0.02% |